Hommel Lab Research
Our research focuses on improving the management of chronic conditions such as inflammatory bowel disease (IBD), eosinophil-associated gastrointestinal disorders (EGID) and cystic fibrosis (CF). We study treatment adherence and self-management, and we systematically develop and test interventions to help patients and families better manage these conditions. We also incorporate new adherence measurement technologies into our research to assess their use and keep patients and families apprised of state-of-the-art self-management tools that may be useful to them. Our overall goal is to improve health outcomes and quality of life for the patients and families with whom we work.
Our current studies focus on children or adolescents diagnosed with IBD, EGID and CF. Since chronic illness management involves the patient’s entire family, our work includes both patients and their families. We have seven active studies: four are randomized controlled trials of interventions to improve adherence and self-management, two are observational studies aimed at measuring treatment adherence and identifying factors related to poor outcomes, and one is a quality-improvement project aimed at facilitating clinician delivery of self-management support to patients and families.
Contact Us
Kevin A. Hommel, PhD
Phone: 513-803-0407
Email: kevin.hommel@cchmc.org
Liz Hente
Phone: 513-803-0920
Email: elizabeth.hente@cchmc.org
Katie Loreaux
Phone: 513-803-1009
Email: katherine.loreaux@cchmc.org
